Monica L. Guzman obtained her B.S. from the University of
Guanajuato (Mexico) in 1997 and completed her Ph.D. in Microbiology, Immunology, and Molecular
Genetics from the University of Kentucky in 2002. She was appointed as Assistant
Professor of Pharmacology in Medicine at Weill Cornell Medical College in 2009,
then was promoted to Associate Professor in 2016. She was awarded the NIH
Director’s Innovator Award (DP2) in 2010, the V-Foundation Scholar in 2010, the
Irma T. Hirschl/Monique Weill-Caulier Investigator Award in 2015, and was listed
in 100 inspiring Hispanic/Latinx scientists in America in 2020. Her lab aims to
(1) identify vulnerabilities in malignant stem/progenitor cells; (2) measure
residual disease; and (3) assess the tumor microenvironment with the purpose of
identifying therapeutic approaches to eliminate malignant cells without harming
their normal counterparts.
Monica L. Guzman obtained her B.S. from the University of
Guanajuato (Mexico) in 1997 and completed her Ph.D. in Microbiology, Immunology, and Molecular
Genetics from the University of Kentucky in 2002. She was appointed as Assistant
Professor of Pharmacology in Medicine at Weill Cornell Medical College in 2009,
then was promoted to Associate Professor in 2016. She was awarded the NIH
Director’s Innovator Award (DP2) in 2010, the V-Foundation Scholar in 2010, the
Irma T. Hirschl/Monique Weill-Caulier Investigator Award in 2015, and was listed
in 100 inspiring Hispanic/Latinx scientists in America in 2020. Her lab aims to
(1) identify vulnerabilities in malignant stem/progenitor cells; (2) measure
residual disease; and (3) assess the tumor microenvironment with the purpose of
identifying therapeutic approaches to eliminate malignant cells without harming
their normal counterparts.